SRAAX Performance — SIMT Real Return Fund, Class F
Data updated: 2026-08-28
SRAAX returned +1.27% year to date and +3.04% over one year to Jun 2026. Annualised returns are +4.74% over 3 years and +2.60% over 5 years. The fund beat its Short-Term Government Bond category average: $100 invested three years ago grew to $115, against $115 for the category, and to $103 over one year, against $103. Volatility over the past three years was 2.03% a year. In the 12 months to Jun 2026 the fund took in a net $14.6M, and assets reached $388.29M.
SRAAX Growth of $100
What $100 invested in SIMT Real Return Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Short-Term Government Bond category average over the same months.
| Period | SRAAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $103 | $103 |
| 3 years (Jul 2023 – Jun 2026) | $115 | $115 |
| 5 years (Jul 2021 – Jun 2026) | $114 | $111 |
| Since data start (Jul 2019 – Jun 2026) | $124 | $118 |
SRAAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.27% |
| 1 year | +3.04% |
| 3 years (annualised) | +4.74% |
| 5 years (annualised) | +2.60% |
SRAAX Annual Returns
Calendar-year total returns of SIMT Real Return Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +1.27% |
| 2025 | +6.04% |
| 2024 | +4.06% |
| 2023 | +4.07% |
| 2022 | −4.41% |
| 2021 | +5.01% |
| 2020 | +5.08% |
| 2019 (Jul–Dec) | +1.27% |
SRAAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.2% | +0.4% | +0.5% | −0.4% | 0.0% | +1.0% | — | — | — | — | — | — |
| 2025 | +1.0% | +1.3% | +0.9% | +0.5% | −0.5% | +0.8% | −0.2% | +1.4% | +0.3% | 0.0% | +0.2% | 0.0% |
| 2024 | +0.5% | −0.4% | +0.4% | +0.6% | +1.0% | −0.2% | +1.1% | +0.5% | +1.1% | −0.4% | +0.4% | −0.7% |
| 2023 | +2.1% | −0.6% | +0.7% | −0.3% | −0.8% | +0.1% | −0.3% | 0.0% | +0.4% | +1.2% | +1.1% | +0.4% |
| 2022 | −0.9% | +1.1% | −0.8% | −1.8% | +0.3% | −0.3% | −3.5% | −1.7% | +2.0% | −0.4% | +0.5% | +1.0% |
| 2021 | +0.6% | −0.1% | +0.6% | 0.0% | +0.7% | +1.0% | −0.2% | 0.0% | +1.4% | +0.1% | +0.3% | +0.6% |
| 2020 | −1.9% | +0.6% | +0.5% | +0.8% | +0.7% | +1.2% | −0.2% | +1.3% | +0.8% | +1.0% | +0.6% | −0.3% |
| 2019 | — | — | — | — | — | — | −0.4% | +0.5% | 0.0% | +0.8% | 0.0% | +0.3% |
SRAAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 2.03%
- 3-year Sharpe ratio: 0.12 (vs 4.5% risk-free rate)
- Best month: +1.43% (Aug 2025)
- Worst month: −0.71% (Dec 2024)
SRAAX Fund Flows
Monthly money in and out of SIMT Real Return Fund, from SEC Form N-PORT.
- 12-month net flow: $14.6M
- 12-month gross sales (incl. reinvestments): $81.1M
- Sales ÷ redemptions: 1.22×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $6.9M | $5.8M | $1.1M |
| May 2026 | $4.8M | $4.7M | $98K |
| Apr 2026 | $4.6M | $5.1M | −$450K |
| Mar 2026 | $5.3M | $5.2M | $56K |
| Feb 2026 | $7.6M | $5.2M | $2.4M |
| Jan 2026 | $6.0M | $5.8M | $147K |
| Dec 2025 | $9.3M | $6.2M | $3.1M |
| Nov 2025 | $5.6M | $6.0M | −$366K |
| Oct 2025 | $10.1M | $4.9M | $5.2M |
| Sep 2025 | $10.4M | $6.2M | $4.2M |
| Aug 2025 | $4.9M | $4.9M | $38K |
| Jul 2025 | $5.6M | $6.5M | −$870K |
SRAAX Assets Under Management
Net assets of SIMT Real Return Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $388.29M |
| 2026-03-31 | $386.73M |
| 2025-12-31 | $381.06M |
| 2025-09-30 | $380.21M |
| 2025-06-30 | $375.83M |
| 2025-03-31 | $379.46M |
| 2024-12-31 | $374.75M |
| 2024-09-30 | $384.26M |
| 2024-06-30 | $380.29M |
| 2024-03-31 | $389.20M |
| 2023-12-31 | $188.24M |
| 2023-09-30 | $197.80M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.